From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.  They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations.  Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Investment Management

OrbiMed

Managing Partners

Jonathan T. Silverstein

Carl L. Gordon

Sven H. Borho

Rishi Gupta

Peter Thompson

Erez Chimovits

Matthew S. Rizzo

William F. Sawyer

Mona Ashiya

Steven D. Wang

David Wang

Trevor M. Polischuk

Iris Wang

W. Carter Neild

C. Scotland Stevens

Geoffrey C. Hsu

David Bonita

The current leadership team at OrbiMed has experience in founding and leading companies in the biotech industry. They have a history of co-founding companies and sitting on boards, as well as experience in the medical field. The team is educated in medicine and molecular biology.

Leadership Team

Partners

General Partners

Leadership Team

About

Team members

Other teams at OrbiMed

Partners

General Partners